Bibliographic Details
| Title: |
Merus' head and neck cancer candidate bolsters 'best-in-disease' profile with new data drop: analyst. |
| Authors: |
Becker, Zoey (AUTHOR) |
| Source: |
FierceBiotech. 12/2/2024, pN.PAG-N.PAG. 1p. |
| Subject Terms: |
Head & neck cancer, Squamous cell carcinoma, Neuregulins, Clinical trials, Cancer research |
| Abstract: |
Along with the company's new data drop, Merus also secured a partner for its first-in-class NRG1 fusion-positive cancer candidate. [ABSTRACT FROM AUTHOR] |
|
Copyright of FierceBiotech is the property of Questex Media Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Business Source Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
